从单细胞克隆到高产型流感病毒生产 - - 在疫苗开发过程中实施先进技术
Tilia Zinnecker1, Najd Badri2, Diogo Araujo3
1Max Planck Institute for Dynamics of Complex Technical Systems Magdeburg Germany.
Engineering in life sciences
|April 8, 2024
概括
这项研究引入了先进的细胞培养技术,用于更快,高产量的流感病毒疫苗生产. 新的单克隆细胞克隆显示出卓越的性能,可能会彻底改变疫苗制造业.
科学领域:
- 病毒学 病毒学
- 生物技术是生物技术.
- 疫苗制造 疫苗制造 疫苗制造
背景情况:
- 目前的流感疫苗生产依赖于过时的方法.
- 细胞培养技术具有潜力,但未得到充分利用.
- 现代化病毒疫苗制造是疫情准备的关键.
研究的目的:
- 评估最先进的细胞培养是否可以改善病毒疫苗开发过程.
- 开发和评估用于流感病毒生产的高性能细胞克隆.
主要方法:
- 为马丁-达比犬 (MDCK) 细胞建立了一个自动化的单细胞克隆策略.
- 在AMBR15系统中使用精选的细胞克隆对流感病毒产生进行查.
- 在更大的工作量下确认了过程可扩展性.
主要成果:
- 鉴定出MDCK细胞克隆C59具有高细胞度 (17.3 × 10^6细胞/毫升) 和低倍增时间.
- 通过克隆C113实现高流感病毒标位,产生高达25,000个病毒/细胞.
- 在50倍增加的规模上证明了成功的流程性能.
结论:
- 介绍了一种可扩展的,单细胞衍生的方法,用于加速开发高产流感病毒的生产.
- 新的细胞克隆显示出在疫苗制造方面超越现有细胞系的潜力.
- 开发的技术为传统的病毒疫苗生产方法提供了强大的替代方案.
相关概念视频
01:27Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...